Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 2, 2008 - Issue 11
Journal homepage
44
Views
1
CrossRef citations to date
0
Altmetric
Review

Diagnosis of pulmonary hypertension

Gerin R Stevens The Center for Advanced Cardiac Care, Columbia-Presbyterian Medical Center, New York, USA
, MD PhD &
Javier Sanz The Zena and Michael A Wiener Cardiovascular Institute, Marie-Josee and Henry R Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, Box 1030, 10029, New York, USA +212 241 6054; +212 241 8872; [email protected]
, MD
Pages 1263-1277 | Published online: 31 Oct 2008

Bibliography

  • Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):S40-7
  • McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of Pulmonary Arterial Hypertension*: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2004;126(1 Suppl):S78-92
  • Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic Thromboembolic Pulmonary Hypertension. N Engl J Med 2001;345(20):1465-72
  • Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):S5-12
  • Humbert M. The burden of pulmonary hypertension. Eur Respir J 2007;30(1):1-2
  • Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107(2):216-23
  • Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982; 2006. Eur Respir J 2007;30(6):1103-10
  • Humbert M, Sitbon O, Chaouat A, et al. Pulmonary Arterial Hypertension in France: Results from a national registry. Am J Respir Crit Care Med 2006;173(9):1023-30
  • McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126(1) Suppl:S14-34
  • Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984;70(4):580-7
  • McLaughlin VV, Rich S. Pulmonary hypertension. Curr Probl Cardiol 2004;29(10):575-634
  • Al-Naamani K, Hijal T, Nguyen V, et al. Predictive values of the electrocardiogram in diagnosing pulmonary hypertension. Int J Cardiol 2008;127(2):214-8
  • Kanemoto N. Electrocardiographic and hemodynamic correlations in primary pulmonary hypertension. Angiology 1988;39(9):781-7
  • Bossone E, Paciocco G, Iarussi D, et al. The Prognostic Role of the ECG in Primary Pulmonary Hypertension. Chest 2002;121(2):513-8
  • Lupi E, Dumont C, Tejada VM, et al. A radiologic index of pulmonary arterial hypertension. Chest 1975;68(1):28-31
  • Matthay RA, Schwarz MI, Ellis JH Jr, et al. Pulmonary artery hypertension in chronic obstructive pulmonary disease: determination by chest radiography. Invest Radiol 1981;16(2):95-100
  • Raymond RJ, Hinderliter AL, Willis PWIV, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002;39(7):1214-9
  • Oh J, Seward J, Tajik A. The Echo Manual. 3rd edition. Philadelphia: Lippincott Williams & Wilkins, 2006
  • Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary Arterial Hypertension: the key role of echocardiography. Chest 2005;127(5):1836-43
  • Ruan Q, Nagueh SF. Clinical application of tissue doppler imaging in patients with Idiopathic pulmonary hypertension. Chest 2007;131(2):395-401
  • Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174(9):1034-1041
  • Lopez-Candales A, Dohi K, Rajagopalan N, et al. Defining normal variables of right ventricular size and function in pulmonary hypertension: an echocardiographic study. Postgrad Med J 2008;84(987):40-5
  • De Castro S, Cavarretta E, Milan A, et al. Usefulness of tricuspid annular velocity in identifying global RV dysfunction in patients with primary pulmonary hypertension: a comparison with 3D echo-derived right ventricular ejection fraction. Echocardiography 2008;25(3):289-93
  • Tei C, Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996;9(6):838-47
  • Vonk MC, Sander MH, van den Hoogen FHJ, et al. Right ventricle Tei-index: A tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr 2007;8(5):317-21
  • Yeo TC, Dujardin KS, Tei C, et al. Value of a Doppler-Derived Index Combining Systolic and Diastolic Time Intervals in Predicting Outcome in Primary Pulmonary Hypertension. Am J Cardiol 1998;81(9):1157-61
  • Hinderliter AL, WillisIv PW, Long W, et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. Am J Cardiol 1999;84(4):481-4
  • Hemnes ARMD, Gaine SPMDP, Wiener CMMD. Poor Outcomes Associated with Drainage of Pericardial Effusions in Patients with Pulmonary Arterial Hypertension. South Med J 2008;101(5):490-4
  • Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990;66(4):493-6
  • Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18(12):1440-63
  • McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical Correlates and Reference Intervals for Pulmonary Artery Systolic Pressure Among Echocardiographically Normal Subjects. Circulation 2001;104(23):2797-2802
  • Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989;80(2):353-60
  • Weyman AE, Dillon JC, Feigenbaum H, Chang S. Echocardiographic patterns of pulmonic valve motion with pulmonary hypertension. Circulation 1974;50(5):905-10
  • Torbicki A, Kurzyna M, Kuca P, et al. Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension. Circulation 2003;108(7):844-8
  • Forfia PR, Mathai SC, Fisher MR, et al. Hyponatremia Predicts Right Heart Failure and Poor Survival in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2008;177(12):1364-9
  • Leuchte HH, El Nounou M, Tuerpe JC, et al. N-terminal Pro-Brain Natriuretic Peptide and Renal Insufficiency as Predictors of Mortality in Pulmonary Hypertension. Chest 2007;131(2):402-9
  • Njaman W, Iesaki T, Iwama Y, et al. Serum Uric Acid as a Prognostic Predictor in Pulmonary Arterial Hypertension With Connective Tissue Disease. Int Heart J 2007;48(4):523-32
  • Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary Hypertension. Chest 2006;129(5):1313-21
  • Nagaya N, Nishikimi T, Uematsu M, et al. Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension. Circulation 2000;102(8):865-70
  • Fijalkowska A, Torbicki A. Role of cardiac biomarkers in assessment of RV function and prognosis in chronic pulmonary hypertension. Eur Heart J Suppl 2007;9(suppl_H):H41-7
  • Sun X-G, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003;41(6):1028-35
  • Steenhuis LH, Groen HJ, Koeter GH, van der Mark TW. Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J 2000;16(2):276-81
  • D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115(5):343-9
  • Waxman AB. Pulmonary Function Test Abnormalities in Pulmonary Vascular Disease and Chronic Heart Failure. Clinics in Chest Medicine 2001;22(4):751-8
  • Minai OA, Pandya CM, Golish JA, et al. Predictors of Nocturnal Oxygen Desaturation in Pulmonary Arterial Hypertension. Chest 2007;131(1):109-17
  • Oikawa M, Kagaya Y, Otani H, et al. Increased [18F]Fluorodeoxyglucose Accumulation in Right Ventricular Free Wall in Patients With Pulmonary Hypertension and the Effect of Epoprostenol. J Am Coll Cardiol 2005;45(11):1849-55
  • Pengo V, Lensing AWA, Prins MH, et al. Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism. N Engl J Med 2004;350(22):2257-64
  • Sostman HD, Coleman RE, DeLong DM, et al. Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism. Radiology 1994;193(1):103-7
  • Ryan KL, Fedullo PF, Davis GB, et al. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest 1988;93(6):1180-5
  • D'Alonzo GE, Bower JS, Dantzker DR. Differentiation of patients with primary and thromboembolic pulmonary hypertension. Chest 1984;85(4):457-61
  • Worsley DF, Palevsky HI, Alavi A. Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med 1994;35(5):793-6
  • Bergin CJ, Hauschildt J, Rios G, et al. Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension. Am J Roentgenol 1997;168(6):1549-55
  • Auger WR, Fedullo PF, Moser KM, et al. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992;182(2):393-8
  • Resten A, Maitre S, Humbert M, et al. Pulmonary Hypertension: CT of the Chest in Pulmonary Venoocclusive Disease. Am J Roentgenol 2004;183(1):65-70
  • Sherrick AD, Swensen SJ, Hartman TE. Mosaic pattern of lung attenuation on CT scans: frequency among patients with pulmonary artery hypertension of different causes. Am J Roentgenol 1997;169(1):79-82
  • King MA, Ysrael M, Bergin CJ. Chronic thromboembolic pulmonary hypertension: CT findings. Am J Roentgenol 1998;170(4):955-60
  • Tunariu N, Gibbs SJR, Win Z, et al. Ventilation-Perfusion Scintigraphy is more sensitive than multidetector CTPA in detecting chronic Thromboembolic Pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;48(5):680-4
  • Bergin CJ, Sirlin C, Deutsch R, et al. Predictors of Patient Response to Pulmonary Thromboendarterectomy. Am J Roentgenol 2000;174(2):509-15
  • Kuriyama K, Gamsu G, Stern RG, et al. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol 1984;19(1):16-22
  • Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999;14(4):270-8
  • Kreitner K-FJ, Ley S, Kauczor H-U, et al. Chronic Thromboembolic Pulmonary Hypertension: Pre- and Postoperative Assessment with Breath-hold MR Imaging Techniques. Radiology 2004;232(2):535-43
  • Nikolaou K, Schoenberg SO, Attenberger U, et al. Pulmonary Arterial Hypertension: Diagnosis with Fast Perfusion MR Imaging and High-Spatial-Resolution MR Angiography–Preliminary Experience. Radiology 2005;236(2):694-703
  • Pujadas S, Reddy GP, Weber O, et al. MR imaging assessment of cardiac function. J Magn Reson Imaging 2004;19(6):789-99
  • Kreitner KF, Ley S, Kauczor HU, et al. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 2004;232(2):535-43
  • Saba TS, Foster J, Cockburn M, et al. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 2002;20(6):1519-24
  • van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28(10):1250-7
  • Sanz J, Dellegrottaglie S, Kariisa M, et al. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol 2007;100(4):731-5
  • Roeleveld RJ, Marcus JT, Boonstra A, et al. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005;22(1):67-72
  • Sanz J, Kuschnir P, Rius T, et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007;243(1):70-9
  • Reiter G, Reiter U, Kovacs G, et al. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging 2008;1(1):23-30
  • Hundley WG, Li HF, Lange RA, et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging: a comparison with oximetric and indicator dilution techniques. Circulation 1995;91(12):2955-60
  • Dellegrottaglie S, Sanz J, Poon M, et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 2007;243(1):63-9
  • Roeleveld RJ, Marcus JT, Faes TJ, et al. Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 2005;234(3):710-7
  • Celermajer DS, Marwick T. Echocardiographic and right heart catheterization techniques in patients with pulmonary arterial hypertension. Int J Cardiol 2008;125(3):294-303
  • Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48(12):2546-52
  • Chemla D, Castelain V, Herve P, et al. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 2002;20(5):1314-31
  • Guillinta P, Peterson KL, Ben-Yehuda O. Cardiac catheterization techniques in pulmonary hypertension. Cardiol Clin 2004;22(3):401-15
  • Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40(4):780-8
  • Park MH. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension. Catheter Cardiovasc Interv 2008;71(2):205-13
  • Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in Idiopathic Pulmonary Arterial Hypertension. Circulation 2005;111(23):3105-11
  • Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327(2):76-81
  • Sitbon O, Humbert M, Jagot JL, et al. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J 1998;12(2):265-70
  • Michelakis E, Tymchak W, Lien D, et al. Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide. Circulation 2002;105(20):2398-403
  • Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;334(5):296-302
  • Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346(12):896-903
  • ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-7
  • Borg G. Ratings of perceived exertion and heart rates during short-term cycle exercise and their use in a new cycling strength test. Int J Sports Med 1982;3(3):153-8
  • Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161(2 Pt 1):487-92
  • Paciocco G, Martinez FJ, Bossone E, et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001;17(4):647-52
  • Gomberg-Maitland M, Huo D, Benza RL, et al. Creation of a Model Comparing 6-Minute Walk Test to Metabolic Equivalent in Evaluating Treatment Effects in Pulmonary Arterial Hypertension. J Heart Lung Transplant 2007;26(7):732-8
  • Hansen JE, Sun X-G, Yasunobu Y, et al. Reproducibility of Cardiopulmonary Exercise Measurements in Patients With Pulmonary Arterial Hypertension. Chest 2004;126(3):816-24
  • Sun X-G, Hansen JE, Oudiz RJ, Wasserman K. Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension. Circulation 2001;104(4):429-35
  • Wensel R, Opitz CF, Anker SD, et al. Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing. Circulation 2002;106(3):319-24
  • Hoeper MM, Oudiz RJ, Peacock A, et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 2004;43(12 Suppl 1):S48-55
  • Hansen JE, Ulubay G, Chow BF, et al. Mixed-Expired and End-Tidal CO2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases. Chest 2007;132(3):977-83
  • Newman JH, Trembath RC, Morse JA, et al. Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol 2004;43(12 Suppl S):S33-9
  • Kubánek M, Málek I, Kautzner J, et al. The value of B-type natriuretic peptide and big endothelin-1 for detection of severe pulmonary hypertension in heart transplant candidates. Eur J Heart Fail 2005;7(7):1149-55
  • Diller G-P, van Eijl S, Okonko DO, et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and Idiopathic Pulmonary Arterial Hypertension. Circulation 2008;117(23):3020-30
  • Grunig E, Janssen B, Mereles D, et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000;102(10):1145-50
  • Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):S13-24

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.